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Abstract 
The ubiquitin proteasome system (UPS) directs programmed destruction of key 
cellular regulators via post-translational modification of its targets with polyubiquitin 
chains. These commonly contain Lysine 48 (K48)-directed ubiquitin linkages, but 
chains containing atypical Lysine 11 (K11) linkages also target substrates to the 
proteasome, for example to regulate cell cycle progression. The ubiquitin ligase 
called the Anaphase Promoting Complex/Cyclosome (APC/C) controls mitotic exit. In 
higher eukaryotes, the APC/C works with the E2 enzyme UBE2S to assemble K11 
linkages in cells released from mitotic arrest, and these are proposed to constitute an 
improved proteolytic signal during exit from mitosis. We have tested this idea by 
correlating quantitative measures of in vivo K11-specific ubiquitination of individual 
substrates, including Aurora kinases, with their degradation kinetics tracked at the 
single cell level. We report that all anaphase substrates tested by this methodology 
are stabilized by depletion of K11 linkages via UBE2S knockdown, even if the same 
substrates are significantly modified with K48-linked polyubiquitin. Specific 
examination of substrates depending on the APC/C coactivator Cdh1 for their 
degradation revealed Cdh1-dependent enrichment of K11 chains on these 
substrates, while other ubiquitin linkages on the same substrates added during 
mitotic exit were Cdh1-independent. Therefore we show that K11 linkages provide 
the APC/C with a means to regulate the rate of substrate degradation in a co-
activator-specified manner. 
 
 
Introduction 
The specificity of substrate targeting by UPS enables precise remodelling of the 
protein landscape in many cellular processes. One such process is mitotic exit, 
triggered by destruction of mitotic cyclin at metaphase and accompanied by 
degradation of many other mitotic regulators, each with distinct timing and kinetics, 
as cells progress through anaphase and return to G1 phase (Min and Lindon, 2012). 
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All of these degradation events are mediated by the APC/C (Pines, 2011). A 
longstanding question in the field, then, is how this single ubiquitin ligase specifies 
temporal degradation for a large number of substrates. Part of the answer lies with 
the temporal specificity of APC/C‟s coactivators, with Cdc20 active from 
prometaphase until its degradation during mitotic exit and Cdh1 from anaphase 
onwards (Pines, 2011). The coactivation mechanism is proposed to function partly 
via recruitment of substrates, and partly through enhancement of ubiquitination 
activity mediated by the APC/C (Barford, 2011), with recent studies attributing the 
latter role to enhanced E2 efficiency and stabilization of E2-APC/C interaction in the 
presence of coactivator (Brown et al., 2014; Chang et al., 2014; Kelly et al., 2014; 
Van Voorhis and Morgan, 2014). 
In mammalian cells, APC/C is thought to act via the concerted activity of two different 
E2s. UBE2C adds the first ubiquitin or short ubiquitin chain to a substrate („priming‟), 
while UBE2S attaches ubiquitin to the already attached ubiquitin molecules, 
elongating polyubiquitin chains in a K11 linkage-specific fashion (Williamson et al., 
2009; Matsumoto et al., 2010; Wu et al., 2010; Wickliffe et al., 2011a). Linkage 
specificity of UBE2S accounts for an abrupt increase in K11 linkages seen in cells 
released from mitotic arrest, when the APC/C reaches its most active state 
(Matsumoto et al., 2010). It is therefore widely accepted that regulation of mitotic exit 
is one of the major roles of K11 chains (Bremm and Komander, 2011; Wickliffe et al., 
2011b), even though UBE2S is not required for destruction of cyclin B1 in 
unchallenged mitotic exit (Garnett et al., 2009). 
A recent study identified Nek2A as a Ube2S-dependent substrate of the APC/C in 
prometaphase (Meyer and Rape, 2014). Interestingly, the authors showed that 
Nek2A was modified with a variety of short chains by UBE2C, with UBE2S 
elongating short chains in a K11-linkage specific manner to generate branched 
chains. Such heterotypic chains were shown to constitute an improved degradation 
signal in prometaphase, when the APC/C is partially inhibited by the spindle 
assembly checkpoint (SAC) (Meyer and Rape, 2014). In mitotic exit however, once 
the SAC is silenced, there is a dramatic rise in K11-containing polyubiquitin 
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conjugates. It is not known how these K11 linkages contribute to degradation of 
specific substrates as cells exit mitosis. 
In this study we combine a cell-based ubiquitination assay that allows quantitative 
interrogation of ubiquitin conjugates on individual substrates (Min et al., 2013; Lee et 
al., 2014), with in vivo degradation assays that allow tracking of their degradation 
kinetics at the single cell level (Clute and Pines, 1999), to advance our 
understanding of the role and regulation of K11 linkages in mitotic exit.  
 
 
Results  
Abundance of K11 chains rises sharply in mitotic exit 
The abrupt increase in K11 linkages in cells released from mitotic arrest suggests 
that K11 linkages could contribute to mitotic exit. However, whereas UBE2S is 
required for efficient mitotic progression following chronic drug-induced SAC 
activation, it is dispensable for mitotic exit in unchallenged mitosis (Garnett et al., 
2009), raising the question of whether the boost of K11 linkages at mitotic exit also 
occurs during unperturbed mitosis. To test this, we synchronized U2OS cells at the 
G1/S phase boundary by double thymidine block and collected samples after release 
into fresh medium over a timecourse that followed progress through mitosis. The 
mitotic peak appeared 10 hours after release as indicated by phosphorylation of 
Histone H3 (Figure 1A). The decreasing level of Aurora A at 12 hours confirmed that 
mitotic exit had begun at this time, and was correlated with a sharp increase in the 
intensity of linkages detected using an antibody specific for K11-linked ubiquitin 
conjugates (Matsumoto et al., 2010) (Figure 1A). All material detected with this 
antibody in mitotic exit extracts was dependent on UBE2S (Figure 1B). We 
concluded that a dramatic increase in abundance of K11 chains accompanies mitotic 
exit, whether or not cells have previously undergone mitotic arrest. 
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APC/C substrates are modified with K11 ubiquitin linkages during mitotic exit 
To investigate the function of K11 linkages during unperturbed mitotic exit, we 
sought to identify K11 acceptors by testing whether specific known anaphase 
substrates of APC/C-dependent proteolysis are modified with K11 linkages. 
We have recently described a sensitive and robust cell-based assay for measuring 
ubiquitinated fractions of exogenously expressed GFP-tagged substrates in cells 
synchronized at mitotic exit, using drug-release protocols that generate a sharp 
boost in K11 linkages (Supplemental Figure S1). We applied this assay to two well-
known anaphase substrates, mitotic kinases Aurora A and Aurora B (AurA and AurB). 
Following purification of AurA- and AurB-Venus from mitotic exit cells, we 
interrogated samples with linkage-specific K11 antibody and with GFP antibody. K11 
linkages were clearly present on both Aurora kinases, and abrogated by siRNA-
mediated depletion of UBE2S (Ube2Si) (Figure 2A, B). Total ubiquitination on Aurora 
kinases was only partially affected, with approximately half of polyubiquitin 
conjugates remaining after Ube2Si (Figure 2A, C). Ubiquitin conjugates detected on 
these substrates were specific to mitotic exit (Supplemental Figure S2). We obtained 
quantifiably comparable results from stable, inducible cell lines (Floyd et al., 2013) or 
from cells transiently expressing AurA-Venus and AurB-Venus (Figure 2B, C). 
Quantifying the total ubiquitin signal as a function of molecular weight as shown in 
Figure 2D, we observed no apparent decrease in size of substrate-ubiquitin 
conjugates after Ube2Si. Therefore depletion of UBE2S did not appear to abolish 
general ubiquitin conjugation in mitotic exit.  
We considered the possibility that there might exist compensatory mechanisms of 
ubiquitination to accommodate cells to UBE2S siRNA treatment, for example an 
increase in multi- versus poly-ubiquitin conjugates (Dimova et al., 2012), which 
would mask the loss of UBE2S-dependent K11 linkages. To test this idea, we used 
ubiquitin chain restriction (UbiCRest) analysis on AurA-Venus purified from untreated 
cells (Mevissen et al., 2013). Digesting with the non-linkage-specific DUB USP21 
abolished all polyubiquitin conjugated to purified AurA-Venus (Figure 2E). Digesting 
with the K11-specific DUB Cezanne (Bremm et al., 2010) depleted the polyubiquitin 
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fraction in a manner that resembled UBE2Si treatment, with all K11 linkages lost and 
total ubiquitin staining partially reduced across the entire molecular weight range 
(Figure 2E). Treatment with K48-specific DUB OTUB1 removed a significant fraction 
of linkages recognized by a K48-specific antibody, whilst having little effect on the 
amount of K11 linkage detected. For Nek2A-like „branched‟ ubiquitination (Meyer 
and Rape, 2014), OTUB1 treatment should have decreased the quantity of K11 
linkages detected. However, OTUB1 did not decrease K11 chains on AurA, 
suggesting that such chains are either of a distinct architecture, or exist as 
unbranched chains, although we cannot exclude that OTUB1 fails to hydrolyse K11-
modified K48 chains efficiently. Regardless, knocking down UBE2S expression 
faithfully reflects specific removal of K11 linkages from AurA and is a valid route to 
interfere with K11 linkage formation in mitotic exit cells. 
 
K11 ubiquitin linkages promote substrate degradation in mitotic exit 
Next, we investigated degradation of individual mitotic exit substrates under 
conditions of Ube2Si, using live cell imaging (Clute and Pines, 1999). We chose five 
substrates that are targeted by APC/C for proteolysis from anaphase onwards. 
These include substrates whose degradation exclusively depends on the coactivator 
Cdh1, namely AurA, AurB and Cdc6, as well as substrates that can be targeted by 
either Cdh1 or Cdc20, namely Plk1 and KIFC1 (Mailand and Diffley, 2005; Floyd et 
al., 2008; Clijsters et al., 2013; Min et al., 2014). 
We expressed fluorescent protein-tagged substrates and traced their levels in single 
cells in asynchronously proliferating cultures. We then normalized fluorescence 
levels to anaphase onset and in silico synchronized cell traces. Knockdown of 
Ube2S did not alter the timing of anaphase onset (Supplemental Figure S3), nor, for 
each of the substrates analysed, the timing of degradation with respect to anaphase 
onset (Figure 3A, B). However, degradation rates for all substrates were decreased 
under these conditions (Figure 3A, B), suggesting that K11 linkages are important in 
efficient degradation of mitotic exit substrates. Moreover, in the absence of UBE2S 
all substrates underwent degradation with similar kinetics despite distinct 
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degradation kinetics under control conditions (Figure 3C, D), indicating that K11 
chains specify accelerated rates of degradation in a substrate-dependent manner.  
 
Regulation of K11 chain formation by APC/C-Cdh1   
Given that the subset of mitotic exit substrates of cellular proteolysis could be major 
contributors to the K11-linked polyubiquitin detected in Figure 1A, we hypothesized 
that Cdh1 activity accounted for the dramatic increase in K11 chain assembly at 
mitotic exit. Indeed, we observed a 60% reduction in K11 linkage after siRNA-
mediated Cdh1 depletion (Cdh1i) (Figure 4A), supporting the idea that K11 linkages 
could be the critical output of Cdh1 specificity in substrate degradation. Therefore we 
interrogated ubiquitin conjugates on individual substrates after Cdh1i. We found that, 
on the exclusively Cdh1-dependent substrates AurA and AurB (Floyd et al., 2008) 
(Supplemental Figure S4 A-D) Cdh1i treatment abolished K11 chains as effectively 
as Ube2Si (Figure 4B-C). By contrast, however, K11 chains on non-Cdh1-dependent 
substrate KIFC1 (Min et al., 2014) (Supplemental Figure S4 E-F), were not largely 
affected by Cdh1i (Figure 4D). 
The coactivation mechanism is proposed to function partly via recruitment of 
substrates to the APC/C via specific motifs (Barford, 2011), and partly through 
enhancement of ubiquitination activity mediated by the APC/C, with recent studies 
attributing the latter role to enhanced E2 efficiency and stabilization of E2-APC/C 
interactions in the presence of coactivator (Brown et al., 2014; Chang et al., 2014; 
Kelly et al., 2014; Van Voorhis and Morgan, 2014). Our results confirm that substrate 
recruitment does not explain the role for Cdh1 in Aurora kinase degradation, since 
total polyubiquitin associated with Aurora kinases was only reduced by 
approximately 50%, with K48 chains still assembled on these substrates, in the 
absence of Cdh1 (Figure 4B-C). Therefore our results indicate that assembly of K11 
chains, but not other linkages, correlates with substrate specificity in degradation 
conferred by Cdh1. 
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A recent study of coactivator function showed that Cdc20 plays a role in UBE2S 
activation by stabilizing the interaction between APC/C and UBE2S (Kelly et al., 
2014). Cdh1 also binds UBE2S (Williamson et al., 2009) and our findings suggest 
that Cdh1 may act in a similar way. In the Kelly et al. study it was reported that 
mitotic exit APC/C was less active in stimulating UBE2S activity than APC/CCdc20, 
based on measurement of UBE2S activity in the presence of Cdh1 and APC/C 
purified from synchronized cell extracts using APC3 antibody. APC3 is a core APC/C 
subunit required for cyclin B degradation in metaphase and proposed to interact with 
Cdh1 (Kraft et al., 2005; Chang et al., 2014). Strikingly, we found that depleting 
APC3 does not abolish assembly of K11 linkage in mitotic exit, either in the whole 
cell lysate or on APC/C substrate AurA (Figure 4E). Therefore APC3 is not required 
for building K11 chains in mitotic exit. Although unexpected, this result can reconcile 
the finding from Kelly et al. that APC3-bound APC/C purified from mitotic exit cells is 
less active in building K11 linkages than that purified from mitotic arrested cells, with 
observations that K11 linkages are several-fold more abundant in mitotic exit cells 
(Figure 1)(Matsumoto et al., 2010). 
 
Discussion 
In this study we have investigated the function of K11 ubiquitin chains in mitotic exit. 
We confirmed that K11 ubiquitin linkages dramatically increase in both unperturbed 
and pharmacologically synchronized mitotic exit, in a UBE2S-dependent manner, 
consistent with the idea that a main cellular function of K11 chain in higher 
eukaryotes is to regulate mitotic exit. Using UBE2S depletion to specifically interfere 
with the assembly of K11 chain, we found that it slowed down degradation of all 
mitotic exit substrates we examined and diminished the kinetic differences in 
degradation that we observe among different substrates. This correlation is also 
present in budding yeast S. cerevisiae, where APC/C and its E2s Ubc4 and Ubc1 
assemble K48 chains only (Rodrigo-Brenni and Morgan, 2007), and where 
degradation of a variety of substrates was shown in a recent study to proceed at 
identical rates (Lu et al., 2014).  
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From an evolutionary viewpoint, K11 chains in higher eukaryotes may serve to 
specialize targeting of substrates to allow for more complex regulation of their 
proteolysis. For example only one Aurora kinase is present in yeast while there are 
three in mammals of which at least two are degraded during mitotic exit. Degradation 
of AurA starts soon after anaphase onset and both its degradation and activity are 
required for assembly of a robust spindle midzone (Floyd et al., 2008; Lioutas and 
Vernos, 2013; Reboutier et al., 2013). Beyond this point in mitotic exit, AurB activity 
is retained at the midbody to surveil abscission (Steigemann et al.) but otherwise 
needs to be degraded to promote respreading of the cell after mitosis (Floyd et al., 
2013). These distinct roles in mitotic exit require that AurA and AurB disappear from 
the cell at different times. K11 linkages could therefore contribute to the temporal 
organization of substrate degradation through specifying different degradation 
kinetics. 
Our investigation of the role of Cdh1 in K11 chain assembly revealed a correlation 
between assembly of K11 chains and substrate specificity in degradation conferred 
by Cdh1, suggesting K11 linkages may play a role in passaging information from 
APC/C coactivators to substrate degradation. How would the process of stimulating 
K11 chain assembly couple with the substrate selectivity of Cdh1? K48 chains can 
still be assembled on Aurora kinases upon Cdh1 depletion, implying that these 
substrates are able to receive K48-linked ubiquitin chains from Cdc20-activated 
APC/C. Indeed, Cdc20 and Cdh1 can both bind to the canonical D-box and KEN box 
motifs (Barford, 2011). In this case, binding of substrate to the APC/C per se may not 
be the only step conferring substrate selectivity: It has recently been shown that 
binding of coactivator increases the affinity of APC/C for an E2 (Chang et al., 2014) 
and, importantly, that in the case of the S. cerevisiae E2 Ubc4, Cdh1-bound 
substrate further enhances E2 activity (Van Voorhis and Morgan, 2014). Therefore, 
substrate-specific stimulation may promote coactivator-dependent recruitment of 
UBE2S. The study from Barford and colleagues lends support to this idea by 
showing that Cdh1 binding induces displacement and flexibility of the APC/C 
catalytic module APC2-APC11 (Chang et al., 2014). Co-activator specificity in 
substrate degradation, mediated by K11 linkages, would by this account arise from 
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coactivator-dependent positioning of the K11-specific machinery at the right 
proximity to substrates. 
We have also shown that, unexpectedly, APC3 - an APC/C core subunit proposed to 
recruit coactivator Cdh1 and Cdc20 (Kraft et al., 2005) - plays a less critical role in 
K11 chain assembly in mitotic exit than Cdh1. APC/C is a highly dynamic enzyme 
that is itself intensively regulated by phosphorylation-dependent interactions. For 
example, APC3 has been shown to be required for Cdc20 binding in metaphase but 
not in prometaphase (Izawa and Pines, 2011). A recent high resolution structural 
study has indicated that whilst the IR tail of Cdh1 binds to the tetratricopeptide repeat 
domain (TPR) of APC3, the Cdh1 N-terminus interacts with APC8, APC6 and APC1 
(Chang et al., 2014). This multivalent interaction may constitute a state space within 
which different combinations of binary interactions define distinct functional outputs 
(e.g. interaction with APC3 is not required for building K11 chains). Alternatively, 
since the TPR lobe of APC/C contains 8 TPRs including APC3, the high density of 
these replicate motifs provides a possibility that Cdh1 can plug into alternative 
positions on the core APC/C. Resolving these ideas will require biochemical studies 
from highly synchronized cell populations. Nevertheless, our result suggests that in 
mitotic exit, binding to APC3 is not required for Cdh1 to support K11 chain assembly.  
Our studies demonstrate the importance of investigating ubiquitination in a cellular 
context. Although in vitro studies have generated extensive knowledge of the 
versatile enzyme activities in the UPS, tracking their activity in cells can reveal 
unexpected detail in how they contribute to cellular functions. 
 
Materials and Methods 
Cell culture and synchronization 
U2OS-bioUb cells and U2OS parental cells were described before in (Min et al., 2014) 
and U2OS-AurB-Venus in (Floyd et al., 2013). A tetracycline-regulated U2OS-AurA-
Venus cell line was created from the same parental line as the U2OS-AurB-Venus 
cells, using pTRE-AurA-Venus plasmid and established procedures (Floyd et al., 
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2013). All U2OS cells were cultured in high glucose DMEM (GE healthcare). Cell 
culture medium was supplemented with FBS (10%), Penicillin-Streptomycin, 
amphotericin B, 500 µg/mL geneticin (all from PAA Laboratories) and 1 µg/mL 
tetracycline hydrochloride (Calbiochem). Tetracycline was removed from medium to 
induce expression of the corresponding construct. Synchronization at mitotic exit 
was achieved using sequential treatments with thymidine (20 hr, 2.5 mM) and 
KIF11/Eg5 inhibitor S-trityl-L-cysteine (STLC, 16 hr, 10 µM) after 3 hours release 
from thymidine. Prometaphase cells were collected by mitotic shake-off and forced 
into mitotic exit by silencing the SAC using AurB inhibitor ZM447439 (10 µM) for 70 
min, unless specified otherwise. Double thymidine synchronization experiment, cells 
were first treated with 2.5 mM thymidine for 20 hr, released into fresh medium for 12 
hr. Then 2.5 mM thymidine was added into the culture for 12 hr before releasing 
again. 
 
Plasmids, siRNA and transfection 
pVenus-AurB (Floyd et al., 2013), pEYFP-Plk1 (Lindon and Pines, 2004), pVenus-
AurA and pVenus-KIFC1 (Min et al., 2014) were as described before. Cloning details 
for pTRE-AurA-Venus are available on request. pVenus-Cdc6 was a kind gift from 
Rob Wolthuis (Clijsters et al., 2013). siRNA sequence targeting APC3, Cdh1 and 
UBE2S were as previously described (Floyd et al., 2008; Garnett et al., 2009; Izawa 
and Pines, 2011). Plasmids and siRNAs were electroporated into cells using the 
Neon transfection system (Life Technology) using a program with voltage of 1150V, 
width of 30 ms and 2 pulses. Each transfection was carried out with 2X106 to 107 
cells with 5 µg plasmid per 100µL transfection or 1 µM siRNA oligo in the 
transfection suspension, respectively.  
 
Cellular ubiquitination assay  
To prepare one GFP-Trap pulldown sample for immunoblotting, about 5X106 cells 
expressing a Venus-tagged substrate were lysed in 100 µL lysis buffer (50 mM Tris–
 12 
HCl pH 7.6, 150 mM NaCl, 1 mM EDTA, 1% (v/v) triton; 1X protease inhibitor 
cocktail (Roche); 1 mM NaF; 1 mM Na3VO4; 50 mM N-ethylmaleimide). Following 
dilution with 900 µL dilution buffer (10 mM Tris–HCl pH 7.6, 150 mM NaCl, 0.5 mM 
EDTA, 1X protease inhibitor cocktail; 1 mM NaF, 1 mM Na3VO4, 50 mM N-
ethylmaleimide), the lysate was cleared by centrifugation, applied to 5 µL pre-
washed GFP-Trap_A beads and incubated for 2 hr at room temperature. The beads 
were then washed with 8 M Urea, 1% (w/v) SDS for 1 min, 10 mM Tris-HCl pH 7.6, 
1M NaCl, 0.5 mM EDTA, 1% (v/v) triton for 3X5 min on roller and briefly rinsed in 1% 
(w/v) SDS. The beads were then boiled in 5 µL 4X sample buffer (Life Technology) 
containing 100 mM DTT for 10 min at 95 °C and the eluted sample was separated 
from the beads by centrifugation at 14000 g. Blots were probed with GFP antibody 
(with a IRDye fluorescent secondary antibody) and indicated ubiquitin antibodies 
(with a HRP-linked secondary antibody) for quantitative detection of unmodified and 
ubiquitinated Venus-tagged substrate, respectively, using a Li-Cor Odyssey® Fc. 
Ubiquitination levels are indicated by the ratio of ubiquitin antibody intensity to GFP 
antibody intensity.  
 
Ubiquitin smear distribution profiling 
The indicated ubiquitin blots were exported from Li-Cor Image studio as a non-
saturated 8 bit image. For each lane, 3 line scans (plot profiles) were measured in 
Image J. The averaged profiles were generated in R using an in house script.  
 
In vivo degradation assay 
Imaging and analysis were performed as described before (Min et al., 2013; Min et 
al., 2014).  
 
Antibodies 
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Antibody From 
Dilution for GFP-
Trap purified 
protein 
Dilution for 
whole cell 
lysate 
Actin Sigma (A 3853)  1:1000 
APC3 Abcam (ab10538)  1:1000 
Aurora A BD Biosciences (610939)  1:1000 
Biotin Cell Signaling (#7075) 1:100 1:1000 
Cdh1 
Tim Hunt (London Research 
Institute, Clare Hall 
Laboratories) 
 1:50 
FK2 Enzo (PW0150) 1:600 1:2000 
GFP Abcam (ab290) 1:2000  
GFP Roche (11814460001) 1:500  
K11  Millipore (MABS107-I) 1:100 – 1:500 1:1000 
K48 Abcam (ab140601) 1:500  
Phospho-
Histone 
H3 
Cell Signaling  1:1000 
tubulin Abcam  1:2000 
UBE2S Abnova (PAB1701)  1:1000 
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Figure 1 Abundance of K11 linkages rises strongly in unperturbed mitotic exit. A 
U2OS cells were synchronized at G1/S boundary using double thymidine block and 
then released into fresh medium. Samples taken at the indicated time points were 
blotted and probed with K11 linkage-specific antibody and other markers. For mitotic 
control samples, cells from double thymidine block were released into fresh medium 
containing 10 µM STLC (S-trityl-L-cysteine) for 16 hr. Spindle Assembly Checkpoint- 
(SAC)- arrested cells were collected by mitotic shake-off, as „mitotic arrest‟ sample. 
AurB inhibitor ZM447439 was used at 10 µM to silence the SAC for 80 min to obtain 
„mitotic exit‟ sample. B U2OS cells treated with siRNA against GL2 (control) or 
UBE2S were synchronized at mitotic exit and harvested 44 hr after transfection for 
immunoblotting with antibodies as indicated. 
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Figure 2 K11 chains are built on Aurora kinases at mitotic exit, in a UBE2S-
dependent manner. A-E U2OS-AurA-Venus cells and U2OS-AurB-Venus cells were 
transfected with siRNA oligos against GL2 (control) or UBE2S for 44 hr. Transfected 
cells were induced for expression of Venus-tagged substrates for 16 hr and 
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synchronized to mitotic exit before harvesting for in vivo ubiquitination assays. A 
K11-specific antibody was used to signal K11 linkage and FK2 antibody for total 
ubiquitin linkages. GFP antibody recognises the Venus tag. B-C Quantifications of 
ubiquitin-modified to unmodified Aurora-Venus measured from A and a further two 
experiments, carried out with cells either inducibly or transiently expressing Aurora-
Venus. In each case the ratio of modified:unmodified substrate was normalized to 
the corresponding control sample (GL2i). The bar chart shows the mean ± s.d. of the 
three independent experiments, showing ratios of K11-specific linkages (B) and total 
linkages (C). D Molecular weight distribution of ubiquitinated Aurora-Venus in control 
or UBE2S-depleted cells in the blots shown in A. E AurA-Venus purified as in A was 
subjected to DUB „restriction‟ analysis. For this assay, AurA-Venus on beads was 
incubated with buffer alone, 1.5 µM USP21, 0.5 µM Cezanne, or 15 µM OTUB1 at 
37 °C for 30 min as previously described (Mevissen et al., 2013). Arrowheads 
indicate unspecific staining of USP21 and OTUB1 by the K11 ubiquitin antibody. 
Quantifications show ubiquitin-modified to unmodified Aurora-Venus. 
 20 
 
 
Figure 3 Efficient degradation of mitotic exit substrates requires UBE2S. A-D U2OS 
cells were transfected with indicated constructs together with control or UBE2S 
siRNA and imaged by fluorescence timelapse microscopy from 24 hr to 48 hr after 
transfection. Fluorescence intensity of Venus over time, in individual mitotic cells, 
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was quantified and plotted as a function of anaphase onset. A In vivo degradation 
curve (lefthand panel) shows averaged intensities normalized to anaphase ± s.d. (n 
≥ 5); degradation rate curve (righthand panel) shows the change in rate over time, 
derived from degradation curves as described in (Min et al., 2013). B Degradation 
curves for indicated substrates under conditions of control (GL2i) or Ube2S 
knockdown (Ube2Si). C Degradation rate curves for mitotic exit substrates under 
control conditions. D Degradation rate curves for mitotic exit substrates after UBE2Si. 
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Figure 4 Regulation of K11 chain assembly by APC/C-Cdh1. A U2OS-bioUb cells 
transfected with siRNA sequence against GL2 (control), Cdh1, or UBE2S were 
synchronized to mitotic exit. Whole cell lysate was interrogated by K11 linkage-
specific antibody and by biotin antibody to show total ubiquitin conjugates. B-D 
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U2OS-bioUb cells were transfected with indicated Venus-tagged constructs together 
with control (GL2) or Cdh1 or UBE2S siRNA sequence, induced for bioUb expression 
for 44 hr and synchronized to mitotic exit. Cellular ubiquitination assays were carried 
out to detect total ubiquitin, K11 linkage and K48 linkage on each substrate. Bar plot 
shows mean measurements from three repeats for AurA and AurB and two repeats 
for KIFC1, with s.d. plotted where 3 repeats are available. In vivo degradation assays 
were carried out in parallel (shown in Supplemental Figure S4, together with 
representative blots to validate depletions. E U2OS-AurA-Venus cells were 
transfected with indicated siRNA and synchronized to prometaphase using a 
sequential thymidine and STLC block. Cells were then released into mitotic exit by 
treating with 300 nM CDK I/II inhibitor for 45 min before harvesting. Whole cell 
lysates (left-hand panel) or AurA-Venus pulldowns (middle panel) were probed for 
ubiquitin conjugates. Whole cell lysates were also tested for knockdown efficacies 
with indicated antibodies (right-hand panel). 
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Figure S1 (related to Figure 1). K11 linkages are enriched in mitotic exit under 
all conditions tested, and are Ube2S-dependent.  
A U2OS cells were synchronized at prometaphase by single thymidine block 
(2.5 mM, 20 hr) followed by STLC treatment (10 µM, 16 hr) to arrest cells at the 
SAC. We find that drug release of SAC-arrested cells gives more synchronous 
mitotic exit than canonical drug washout protocols. We collected STLC-arrested 
cells by mitotic shake-off and released them using either ZM447439 (10 µM) or 
CDK I/II inhibitor (300 nM) for indicated time. Immunoblotting of cell extracts 
showed strong enrichment of K11 linkages, as in Figure 1A. B Cells treated with 
siRNA against Ube2S were co-transfected with siRNA-resistant versions of 
Ube2S (wild-type, or catalytically inactive C95A), synchronized at mitotic exit 
and examined by immunoblotting for the presence of K11 ubiquitin linkages. 
These were quantified relative to β-tubulin loading control. 
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Figure S2 (related to Figure 2) Ubiquitin chains on AurA and AurB detected in 
our cellular ubiquitination assays were highly specific to mitotic exit. AurA-Venus 
cells and AurB-Venus cells were synchronized to prometaphase using a 
sequential thymidine and STLC block and collected by mitotic shake off. Half 
were harvested as the mitotic arrest (M) sample and the remainder released 
using ZM before harvesting, for the mitotic exit (C phase) sample. Immunoblot of 
cell lysates using antibody against APC3 shows the dephosphorylation-
dependent increase in mobility of APC3 that provides a marker for mitotic exit. 
Venus-tagged Aurora kinases were purified for ubiquitination assays to show 
that all ubiquitination linkages detected on AurA- and AurB-Venus (in our assays) 
are specific to mitotic exit. 
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Figure S3 (related to Figure 3). Ube2S is not required for unchallenged mitotic 
exit. 
Time taken from Nuclear Envelope Breakdown (NEBD) to anaphase was 
measured in timelapse movies of unsynchronized cell populations treated for 
48h with control siRNA (GL2i) or siRNA against Ube2S (Ube2Si). GL2i, n=28; 
Ube2Si, n=82. p=0.26, Student’s t-test. 
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Figure S4 (related to Figures 3 and 4) Degradation of AurA and AurB are 
sensitive to Cdh1 depletion whilst degradation of KIFC1 is not. Cells co-
transfected with Venus-tagged substrates and siRNA oligos against GL2 
(control), Cdh1 or UBE2S, from the same experiments shown in Figure 4, were 
filmed by fluorescence timelapse microscopy for the substrate degradation 
assays described in Figure 3. A, C, E, validation of siRNA-mediated depletions 
by immunoblot; B, D, F, degradation curves and degradation rate curves for the 
indicated substrates. GL2i and UBE2Si curves are generated from the data 
used for Figure 3. 
